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Abstract
Objectives: The primary objective of this study is to assess three domains - the knowledge, attitude and practice related to the 
Intrauterine Contraceptive Device (IUCD) among primary health care providers (physicians and nurses) in Oman. The secondary 
objective is to compare the IUCD-related knowledge, attitude and practice of health care providers in primary health care between 
physicians and nurses.
Methods: A descriptive cross-sectional survey was conducted in primary health care centers in Muscat region of Oman from May, 
2014 until September, 2015. The survey was a self-administered questionnaire contained questions to assess factual knowledge, 
attitudes and practice of IUCD. The questionnaire was distributed to female health care providers only. Data was collected by 
researchers and analyzed using SPSS version 20. 
Results: Total 269 primary health care providers completed the questionnaire. 109 (40.52%) participants had good and 131 (48.70%) 
had average actual knowledge related to IUCD. The main reasons providers cited for not recommending the IUCD were concerns 
about the side effects; 174 (64.68%) mentioned that it causes bleeding and 127 (47.21%) reported that it needs service provider. Only 
140 (52.43%) of the providers would routinely recommend IUCD to their clients.
Conclusion: Future educational programs for health care providers should address the educational needs in the identified areas 
including misconceptions with regards to IUCD failure rate and side effects. Future training programs are also required to increase 
the technical competence of insertion and confidence in handling the side effects of IUCD. 
Keywords: Family planning, nurse, doctors, IUCDs, Oman, contraception, health knowledge, attitudes, practice, surveys and 
questionnaires.
INTRODUCTION
Intrauterine device (IUCD) is a safe, long term reversible 
contraceptive method that can be used for most women 
with few side effects [1-3]. Worldwide this method is 
under-utilized despite being available and effective [1, 
2, 4-6]. In Oman, since 1994 contraception services are 
provided to all married couples in primary health care 
centers including Cu38A IUCD [5, 7]. These services 
are provided by the government free of charge. Despite 
being available, accessible and free of charge, IUCD 
in Oman is underutilized [5, 8]. In 2008, National 
Reproductive Health Survey in Oman was conducted 
to evaluate family planning utilization and unmet needs, 
knowledge and attitude of IUCD use, maternal health 
care in married Omani females from 15 to 49 years of 
age. The survey revealed that the IUCD is less used 
compared to other contraceptive methods [5]. It also 
showed that health care providers are the main source 
of women’s information about IUCD, and there is a deficit 
in the knowledge about IUCD benefits and side effects 
among Omani women [5, 9]. According to the yearly 
national health report released by Ministry of Health, 
Oman, in 2012 the IUCD was the least utilized compared 
to other contraceptive methods. Clients’ preferences 
were progesterone only pill (33.2%), injectable (28.4%), 
condom 18.1%, Combined Oral Contraceptives (COC) 
(11.7%) and IUCD (8.4%). In the most recent report of 
2017, the IUCD had become the second least utilized 
with a marginal improvement to 13.6 %, followed by COC 
(11.5%) [10, 11]. The majority of clients (93.1%) were 
satisfied with the method they were using and intended 
to continue using it [10, 11]. Across the years, more than 
93% of clients have identified health care providers as 
the main source of their knowledge about contraceptive 
methods [10, 11].
Although utilization of contraception is influenced by 
many factors, there are evidence that lack of knowledge 
among clients and providers about IUCD is the main 
reason behind the under-utilization of IUCD [1, 7-9, 12-
14]. Studies have shown that physician knowledge, 
attitudes and practice do play a big role in the utilization 
of contraceptive methods in addition to the individual 
medical eligibility criteria [4, 15]. There are evidences 
in different populations that physicians are reluctant to 
recommend IUCDs except in narrowly selected patients 
due to several factors, including a lack of training in use 
of IUCDs during residency, a fear of litigation, and a 
belief that the IUCD creates a high risk for PID [15, 16]. 
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These concerns were not unique to primary health 
care providers but are also consistent for obstetrician-
gynecologists. When obstetricians and gynecologists 
were surveyed for their clinical use of IUCD, attitudes 
and how they select IUCD candidates; the results were 
similar to those of primary health care providers [17]. 
One important outcome of those studies that “many 
women could safely use the IUCD but are not offered” 
[17]. Educating physicians about the safety of IUCDs 
may expand their use and then more women would be 
offered this convenient, safe, and highly effective long-
term contraception as shown by randomized clinical 
trials and expert opinion [3, 4, 18, 19]. There are several 
studies exploring the end-user perspective in Oman 
on IUCD use [7-9, 11]. However, so far there are no 
published studies assessing IUCD-related knowledge, 
attitudes and practice among health care providers in 
Oman.
The primary objective of this study is to assess three 
domains -knowledge, attitudes and practice related to 
the IUCD as a contraceptive method among primary 
health care providers (physicians and nurses) in Oman. 
The secondary objective is to compare the IUCD-related 
knowledge, attitude and practice between physicians 
and nurses in primary health care.
MATERIALS AND METHODS
A descriptive cross-sectional survey was conducted in 
2015 over a 5-month period (from May to September) 
in Muscat region, the capital area of Oman, assessing 
the knowledge, practice and attitudes of health care 
providers in primary health care facilities towards 
the use of Copper Intra-Uterine Device (IUCD) as a 
contraceptive method. 
In 2015, Muscat region had total of 22 health centers. 
These health centers provide primary health care 
services including contraception services. Each health 
center had family physicians, general practitioners and 
nurses in addition to other technical and administrative 
staff. The nurses were involved in providing education 
about contraceptive methods and assisting doctors 
during the insertion procedure. The contraceptive 
services were provided only by female physicians and 
nurses. Twenty-one health centers of the total 22 were 
included in the study. One was excluded because it did 
not provide IUCD-insertion services. In those health 
centers, a total number of doctors and nurses were 525 
(210 doctors and 315 nurses). As the total number of 
doctors and nurses working in Muscat health centers 
were 525, the calculated sample size was 223 by taking 
level of confidence as 95% and margin of error as 5%. 
Check market sample size calculator was used for 
sample size calculation [20]. Sample size was inflated 
up to 34% considering the non-response rate. Therefore, 
total 300 participants were approached.
Out of 300 forms distributed to 125 doctors and 175 
nurses to make sure that both doctors and nurses 
were included in the study, 269 forms were filled with 
a response rate of 89.67%. The researchers visited 
the health centers and supplied hard copies of the 
questionnaire to the head of the health center or to the 
chief staff nurse and the questionnaire was randomly 
distributed among the health center nurses and doctors. 
Doctors and nurses who agreed to participate were 
given a written consent form which was included in the 
questionnaire. The consent form contained information 
about the objective, nature of the research and the 
contact details of the researchers. Then the completed 
questionnaires were returned back to the researchers 
through the responsible person in each health center. 
The self-administered questionnaire was modified from 
previous two studies investigating the IUCD-related 
knowledge, attitudes and practices among health 
care providers offering insertion of Copper IUCD and 
Levonorgestrel Intrauterine System (LNG-IUS) [15, 
17]. The modifications were mainly made in the section 
assessing practice to fit the local practice in Oman. The 
study was approved by the Ministry of Health Research 
and Ethics Committee of the Directorate of Muscat. 
The survey had 4 parts with total 15 questions. The 
first was about the Socio-demographic characteristics 
of the participant and the second, third and fourth parts 
were on IUCD-related knowledge, attitude and practice 
respectively. 
The knowledge was assessed through four multiple-
choice questions. The first 2 questions requested the 
participant to indicate all the possible advantages 
and disadvantages of IUCD included in the list. The 2 
questions together had 11 options which were all correct. 
Question one had 9 options and question two had 3 
options. The third and fourth questions that were used to 
assess knowledge requested the participant to indicate 
the correct answer out of four possible options. One was 
regarding the failure rate of IUCD which is known to be 
less than 1%, and the last question was regarding the 
duration of use of IUCD approved by American Food 
and Drug Administration (FDA) which is known to be 10 
years.
The level of knowledge was measured by questions 1-4. 
According to the number of correct items indicated by 
the participants the level of knowledge will be scored. 
The total possible correct answers were 13. Level of 
knowledge was categorized as follows: poor knowledge 
if the participant scored 0 to 4, average knowledge was 
5 to 8, and good knowledge was 9 to 13.
The attitude was assessed by two questions. One was 
asking health care providers about the factors that might 
negatively influence their own decision to recommend 
IUCD by choosing from a list of potential or possible 
factors. Examples of those include; increases risk of PID, 
sexually transmitted infections (STI), irregular bleeding, 
dysmenorrhea, infertility, medical liability and associated 
expenses. They were also requested to indicate any 
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other additional factors that have a role in their decision 
but not included in the list. The second question was 
asking health care providers to indicate why the clients 
might decline using the IUCD as a contraceptive method. 
They were offered a list of potential factors and were 
requested to add any other factors not included in the 
list.
The practice was assessed with four questions about 
attendance of IUCD insertion workshop for providers, 
attendance of educational activities like seminars, 
workshops or conferences around IUCD, and how 
many IUCD the provider has inserted in their carrier. 
In addition, health care providers were requested to 
indicate whether they do recommend IUCD for women 
who desire future pregnancy; routinely, only if other 
methods are unacceptable or unavailable or not at all. 
This question was included to assess the practice when 
it comes to this group of women who constituted the 
majority of women desiring contraception. 
The data was analyzed using the Statistical Package for 
the Social Sciences (SPSS) version 20. Frequency and 
percentages were computed for categorical variables. 
Mean ± standard deviation was used to express 
quantitative variables. Independent t-test was used to 
compare quantitative variable among two groups. Chi-
square or Fisher-exact test was applied to compare 
qualitative variables among nurses and physicians. 
P-value of <0.05 was taken as statistically significant.
RESULTS
Of the 300 distributed questionnaires, with a response 
rate of (89.67%), 269 questionnaires were completed 
and returned from the participating health centers. The 
responders were 135 (50.19%) primary health care 
physicians and 134 (49.81%) nurses. The majority of 
participants (n=196, 72.86%) were 30 to 49 years of 
age, and 64 (23.79%) were between 25-29 years and 
few (n=9, 3.35%) were older than 50 years. Almost 
half (n= 141, 52.41%) of the participants have been in 
practice for 5 to 14 years as shown in Table 1.
In the knowledge domain, the questionnaire included a 
list of IUCD advantages. The majority (n=227, 84.39%) 
of health care providers agreed that IUCD provides long 
term protection while 186 (69.14%) thought that it is very 
effective. The percentages for other advantages were 
also high for example; no interference with intercourse 
(n=163, 60.59%), no interference with breast feeding 
(n=174, 64.68%), no need for frequent follow up (n=183, 
68.03%) and immediate return of fertility once removed 
(n=192, 71.38%). When the knowledge of IUCD 
advantages was compared between doctors and nurses; 
in advantages list, the average items selected by doctors 
and nurses were 8 and 6.9 respectively that indicated 
the significant difference in the knowledge between the 
2 groups. The doctors showed better knowledge than 
nurses (p<0.001). 
When the knowledge of disadvantages of IUCD was 
assessed, 106 (39.41%) of the health care providers 
were aware that IUCD may cause prolonged and heavy 
period, 133 (49.44%) knew that it may cause increased 
pain with periods or dysmenorrhea. 158 (58.74%) of the 
health care providers agreed that it might cause vaginal 
discharge. When the knowledge of disadvantages of 
IUCD was compared between doctors and nurses, in 
disadvantages list the average items selected by doctors 
and nurses were 1.93 and 1.82 respectively and no 
significant difference was observed among doctors and 
nurses knowledge regarding disadvantages of IUCD 
(p=0.335). 
The third question on knowledge was about the failure 
rate for IUCD that is taken to be less than 1% per year. 
Of the physicians, 72 (53.33%) correctly answered this 
question and 40 (29.85%) of the nurses with (p=0.002) 
which indicated a significant difference in the knowledge 
of this information between nurses and physicians. 
The last question to assess the knowledge was on the 
duration of use of Copper IUCD as approved by FDA 
which was 10 years. 94 (69.63%) doctors have chosen 
the correct response while nurses were 70 (52.24%) 
who correctly answered. Proportion of doctors who had 
correct knowledge regarding duration was significantly 
higher than nurses (p=0.002).
When categorizing the health care providers according to 
level of IUCD-related knowledge, 29 (10.78%) had poor 
knowledge, 131 (48.70%) had average knowledge and 
109 (40.52%) had good knowledge. Table 2 compares 
the level of knowledge between physicians and nurses 
showing that physicians had more knowledge compared 
to nurses (p<0.001).
In the Attitudes domain, in the providers opinion, the 
most frequent factors negatively influence patients’ 
decision to use IUCD as a contraceptive method was 
the side effects of bleeding as indicated by 174 (64.68%) 
of providers; 83 (61.48%) of doctors and 91 (67.91%) of 
nurses ( p= 0.306). Followed by the fact that it needs a 
service provider for insertion as indicated by 79 (58.52%) 
of the doctors and 48 (35.82%) of the nurses. Health 
care providers were asked about factors that negatively 
Table 1: Socio-demographic characteristics of the participants.
Variables Groups Frequency (%)
Age group 25-29 years 64 (23.79)
30 to 49 years 196 (72.86)
≥50 years 9 (3.35)
Marital status Single 33(12.27)
Married 235 (87.36)
Divorce 1(0.37)
Healthcare provider Doctors 135(50.19)
Nurses 134 (49.81)
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Table 2: Comparison between doctors and nurses responses to the study questionnaire.






Q1: Advantages of IUCD
effectiveness 186 (69.14) 109 (80.74) 77 (57.46) **<0.001
long protection 227 (84.39) 120 (88.89) 107 (79.85) *0.037
doesn’t interfere with intercourse 163 (60.59) 96 (71.11) 67 (50.00) **<0.001
once removed could conceived 192 (71.38) 108 (80.00) 84 (62.69) **0.002
no reminding 163 (60.59) 89 (65.93) 74 (55.22) 0.071
few follow up 183 (68.03) 101 (74.81) 82 (61.19) *0.016
no breast feeding interference 174 (64.68) 101 (74.81) 73 (54.48) **<0.001
minimize cancer risk 213 (79.18) 110 (81.48) 103 (76.87) 0.345
Q2: Disadvantages of IUCD
long period time /excessive 106 (39.41) 50 (37.04) 56 (41.79) 0.368
increase  period pain 133 (49.44) 63 (46.67) 70 (52.24) 0.298
ulcer and discharge 158 (58.74) 80 (59.26) 78 (58.21) 0.978
Q3: Failure rate of IUCD
None 15 (5.58) 7 (5.19) 8 (5.97)
**0.001
Less than 1% 112 (41.64) 72 (53.33) 40 (29.85)
1 – 3 % 128 (47.58) 51 (37.78) 77 (57.46)
3 – 6 % 14 (5.20) 5 (3.70) 9 (6.72)
Q4: Duration of IUCD use approved by FDA
3 years 20 (7.43) 4 (2.96) 16 (11.94)
**0.003
5 years 57 (21.19) 28 (20.74) 29 (21.64)
10 years 164 (60.97) 94 (69.63) 70 (52.24)
Don’t know 28 (10.41) 9 (6.67) 19 (14.18)
Overall Knowledge 
Poor 28 (10.41) 12 (8.89) 16 (11.94)
**<0.001Average 131 (48.70) 47 (34.81) 84 (62.69)
Good 109 (40.52) 76 (56.30) 33 (24.63)
Attitude
Q5: Factors that negatively influenced the decision to recommend
Increase risk of PID, STI and or infertility 75 (27.88) 51 (37.78) 24 (17.91%)
**0.003
Medical liability 16 (5.95) 9 (6.67) 7 (5.22%)
Increased uterine cramping /pain 93 (34.57) 38 (28.15) 55 (41.04%)
Irregular period 62 (23.05) 26 (19.4) 36 (26.67%)
Expense 7 (2.60) 2 (1.48) 5 (3.73%)
Q6: Why clients might decline using IUCD as contraceptive methods?
causes pain 85 (31.60) 42 (31.11) 43 (32.09%) 0.896
causes bleeding 174 (64.68) 83 (61.48) 91 (67.91%) 0.306
can make a hole in uterus 29 (10.78) 18 (13.33) 11 (8.21%) 0.169
ineffective 9 (3.35) 5 (3.70) 4 (2.99%) ƚ1.00
other methods are easier to use 96 (35.69) 47 (34.81) 49 (36.57%) 0.799
husband reject 101 (37.55) 51 (37.78) 50 (37.31%) 0.900
religious 50 (18.59) 27 (20.00) 23 (17.16%) 0.531
doctor advise for non-use 7 (2.60) 3 (2.22) 4 (2.99%) ƚ 1.00
difficult to put and remove 48 (17.84) 21 (15.56) 27 (20.15%) 0.339
need service provider for insertion and removal 127 (47.21) 79 (58.52) 48 (35.82%) **<0.001
need female doctor 115 (42.75) 59 (43.70) 56 (41.79%) 0.711
Practice
Q7: Would you recommend IUCD to a woman who: (choose more than one)
Is nulliparous 29 (10.78) 15 (11.11) 14 (10.45%) 0.844
Has history of STI or PID 36 (13.38) 16 (11.85) 20 (14.93%) 0.471
Has past history of ectopic pregnancy 52 (19.33) 23 (17.04) 29 (21.64%) 0.350
Is younger than 20 years old 53 (19.70) 26 (19.26) 27 (20.15%) 0.877
Breast feeding 169 (62.83) 94 (69.63) 75 (55.97%) 0.011
Post-partum  167 (62.08) 86 (63.70) 81 (60.45%) 0.505
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influenced their decision to recommend, the highest 
reported factor was increased uterine cramp/pain (n=93, 
34.57%).
When assessing the IUCD-related practice; only 43 
(32.33%) of the doctors and 12 (9.02%) of the nurses 
had attended an educational activity about IUCD, like 
a workshop or a conference. Of the nurses, 9 (6.81%) 
had training on assisting in the insertion procedure. Of 
the physicians, 40 (30.30%) had training on the IUCD 
insertion techniques. Of the physicians, 74 (55.63%) 
never inserted IUCD in their carrier, 36 (27.07%) 
inserted up to 50 IUCDs, and 15 (11.11%) have inserted 
more than 100 during their carriers. Of the nurses, 
77 (59.53%) never assisted in IUCD insertion in their 
carrier, 44 (33.84%) assisted in IUCD insertion up to 50 
times, and 3 (2.24%) have assisted in IUCD insertion 
more than 100 times during their carriers. More than 
half of healthcare providers (n=140, 52.43%) would 
routinely recommend IUCD to women desiring more 
kids in the future, 97 (36.32%) do recommend it only if 
other methods are unacceptable and 30 (11.15%) never 
recommend IUCD to a woman desiring future fertility. 
86 (64.44%) of doctors reported that they routinely 
recommend while nurses were only 54 (40.30%) who 
responded that they routinely give recommendation for 
IUCD (see Table 2 for more details). 
We attempted to establish an association between 
the level of knowledge of the health care provider and 
the likelihood of her practice to recommend IUCD 
for women desiring future pregnancy. 80 (56.74%) of 
those with good knowledge would recommend IUCD 
and 7(23.33%) of those with poor knowledge would 
recommend it. Although it seemed that those with 
good knowledge were more likely to recommend IUCD 
compared to those with poor knowledge; the difference 
between the groups was not significant (p=0.233). 
DISCUSSION
On assessing the IUCD-related knowledge of primary 
health care providers in Oman, 109 (40.52%) of them 
had good knowledge. This is relatively lower level of 
knowledge when compared to other studies where 
69-78% of health care providers had good IUCD-
related knowledge [15, 17]. In both of these studies the 
participants were all physicians. No previous studies 
assessed the level of IUCD-related knowledge among 
nurses involved in IUCD services.  However, the level 
of knowledge varied depending on which aspect of 
knowledge was assessed. The knowledge related to 
the advantages of IUCD was good and 84.39% study 
participants were aware that IUCD provided long term 
contraception.
They were also aware that IUCD is effective, associated 
with quick return of fertility after removal and does not 
interfere with sexual intercourse and breast feeding. The 
poor knowledge was related to its failure rate, as only 
41.64% of the health care providers (53.33% physicians 
and 28.85% nurses) answered correctly. That was a 
disappointing finding as it is an important fact when 
counseling women for IUCD use. When comparing the 
level of knowledge between physicians and nurses, 
physicians had better knowledge than nurses in the 
collective IUCD-related knowledge, in the knowledge 
of IUCD-advantages, failure rate and FDA-approved 
duration of use. However, both professions were similar 
in knowing the disadvantages of IUCD. 
Although insufficient knowledge among health care 
providers about IUCD is likely to discourage them from 
recommending it for use, in this study we were not able 
to establish a statistically significant association between 
the level of knowledge of the health care provider and 
the likelihood of recommending IUCD for contraception 
for women desiring future pregnancy. The reason was 
likely to be that generally there is a low preference of 
health care providers to recommend IUCD for use 
compared to other available methods like combined oral 
contraceptives [10, 11]. The other possible reason for 
the non-significant association between the knowledge 
and likelihood of recommending IUCD was that the 
knowledge measured here was a factual knowledge and 
Q8: Do you recommend the IUCD for women who desire more children in the future?
Recommend routinely 140 (52.43) 86 (64.44) 54 (40.30)
**<0.001Recommend only if other methods are unacceptable 97 (36.32) 36 (27.06) 61 (45.52)
Never recommend 30 (11.15) 11 (8.15) 19 (14.18)
Q9: Any training program for IUCD? 
Yes 55 (20.67) 43 (32.33) 12 (9.02)
**<0.001
No 213 (79.18) 91 (67.41) 122 (91.04)
Q10: IUCD insertions techniques training?
Yes 49 (19.33) 40 (30.30) 9 (6.81)
**<0.001
No 217 (80.67) 93 (68.89) 124 (92.54)
Q11: How many numbers of IUCD inserted during your career?
None 151 (57.41) 74 (55.63) 77 (59.23)
*0.029 
1-20 63 (23.95) 26 (19.54) 37 (28.46)
21-50 17 (6.32) 10 (7.41) 7 (5.22)
51- 100 14 (5.20) 8 (5.93) 6 (4.48)
>100 18(6.69) 15 (11.11) 3 (2.24)
ƚ: Fisher-exact test is reported, * significant at p<0.05, **significant at p<0.01.
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did not necessarily mean a confidence in counseling, 
insertion and handling complications. This was the type 
of knowledge that was shown in several studies to really 
make a difference in practice [3, 4, 19]. The overall 
negative attitudes were illustrated by primary health 
care providers indicating several barriers that negatively 
influenced their decision to recommend IUCD as a 
contraceptive method. Those factors were mainly related 
to exaggerated concerns about the IUCD’s safety and 
side effects which are the same factors reported in other 
studies [15, 17]. Despite several studies confirming the 
safety of IUCD [1-3] the reported rate of PID related 
to IUCD-use was approximately 1.6 per 1000 woman-
years of use [21]. However, in our study, still 27.88% 
healthcare providers put it as a concern for IUCD 
use. This finding of misconceptions and inadequate 
knowledge about IUCD is not unique to the health care 
providers in Oman [5, 9]. It has been shown in different 
health care settings including high income countries like 
United States of America (USA), low income countries 
like Nepal and specific ethnic groups like Navajo Nation 
which is a Native American group [15, 17, 18, 22, 23]. 
Primary health care providers in Oman also reported 
several reasons in their opinion why IUCD was under-
utilized by clients. Those factors were related to different 
aspects including the IUCD-side effects (heavy periods, 
dysmenorrhea and risk of uterine perforation), logistical 
(availability of female provider, ease of insertion, 
availability of other methods that were easier to use) 
and social factors like the opinion of the husband and 
religious concerns). These multiple factors from different 
aspects reflect the overall negative attitude regarding 
IUCD use among health care providers. 
In a randomized clinical trial of health care providers 
conducted in USA, the whole team of health care 
providers in clinics providing contraception services 
were supplied with educational (didactic and hands-on) 
training for IUCD and compared with a control group in 
clinics that were not included in the training. Comparing 
the knowledge, attitudes and practices of the health 
care providers before the training and one year after the 
training showed significant improvement and also when 
comparing the health care providers between the trained 
group and the control group [3, 4, 19]. It is important for 
health policy makers in Oman to work on the issues of 
both clients and health care providers to optimize the 
utilization of the IUCDs, beyond the simple fact of making 
it available and accessible. We believe it is important to 
introduce changes to improve the utilization of the IUCD 
as a contraceptive method. Providing IUCD-training 
courses to all those involved in providing the service, 
monitoring the uptake and auditing practice are some of 
the ways we suggest to improve the utilization of IUCD 
as a contraceptive method. 
Strengths of our study: It is the first in Oman to explore the 
role of health care providers’ knowledge, attitudes and 
practice pertaining to IUCD utilization as a contraceptive 
method. 
Since the study was limited to Muscat region as an urban 
area and no representation of more rural areas in the 
country this might limit the generalizability of the results 
to different socio-demographic settings. Also, it included 
primary health care centers from government sector with 
no representation from private health care sector. This is 
expected to have small if any effect on the quality of the 
data because the majority of contraception services are 
provided by government institutions.  
CONCLUSION
Almost half of the primary health care providers have 
good IUCD-related knowledge and carry favorable 
attitudes towards IUCD use as a contraceptive method. 
Further training and mentoring should address the 
educational needs in the specific identified areas 
including misconception that IUCD increases risk of PID 
and to increase the technical competence of insertion 
and confidence in handling the side effects of IUCD. 
Such training opportunities are expected to improve the 
knowledge, liberate attitudes and boost the providers’ 
confidence in the practice of counseling women for 
IUCD which in turn is expected to generate demand for 
this safe, reliable, long term and reversible contraceptive 
method.
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